title: Survivorship care plans in research and practice.
abstract: The Institute of Medicine (IOM) recommends the use of survivorship care plans (SCPs) for all cancer survivors. Developing useful SCPs requires understanding what survivors and their providers need and how SCPs can be implemented in practice. Published studies investigating the perspectives of stakeholders (survivors, primary care providers, and oncology providers) were reviewed regarding the content and use of SCPs. All National Cancer Institute (NCI)-designated cancer centers were surveyed concerning the extent to which SCPs for survivors of breast and colorectal cancers are in use, their concordance with the IOM's recommendation, and details about SCP delivery. Survivors and primary care providers typically lack the information the IOM suggested should be included in SCPs. Oncology providers view SCPs favorably but express concerns about the feasibility of their implementation. Fewer than one-half (43%) of NCI-designated cancer centers deliver SCPs to their breast or colorectal cancer survivors. Of those that do, none deliver SCPs that include all components recommended by the IOM. Survivors' and providers' opinions about the use of SCPs are favorable, but there are barriers to implementation. SCPs are not widely used in NCI-designated cancer centers. Variation in practice is substantial, and many components recommended by the IOM framework are rarely included. \
authors.affiliation: Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY  10065, USA. salzt@mskcc.org
authors.forename: Talya
authors.initials: T
authors.lastname: Salz
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Oeffinger
authors.forename: Mary S
authors.initials: MS
authors.lastname: McCabe
authors.forename: Tracy M
authors.initials: TM
authors.lastname: Layne
authors.forename: Peter B
authors.initials: PB
authors.lastname: Bach
mesh_terms: D002173:Cancer Care Facilities; D003266:Continuity of Patient Care; D006801:Humans; D008495:Medical Oncology / Q000639:trends*; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000401:mortality / Q000628:therapy*; D010347:Patient Care Planning; D017741:Survivors; D014481:United States / Q000453:epidemiology